Generated

Sanofi releases half-year financial report for 2026, highlighting its commitment to R&D-driven biopharma growth.

Sanofi announced that its half-year financial report for the period ending June 30, 2026, is now available online and has been filed with the French market regulator and the US Securities and Exchange Commission. The report, which can be found on the official website, details the company's performance as an R&D-driven, AI-powered biopharma company. Sanofi remains committed to improving people's lives by applying a deep understanding of the the immune system to invent medicines and vaccines. The company aims to address urgent healthcare, environmental, and societal challenges through an innovative pipeline that could benefit millions more. Investors can download the full document from the 'Investors' page under the heading 'Financial Reports and Other Publications.'

Sources